Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for the restricted use of Bharat Biotech's COVID-19 vaccine and asked the government to explain why mandatory protocols and verification of data has been dispensed with. India's drugs regulator DCGI on Sunday approved Oxford's COVID-19 vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use.
As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, quoting such speculations as "absolute rubbish". "We will never approve anything if there is even the slightest safety concern. Vaccines are 110 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It (rumours of impotency) is absolute nonsense," VG Somani, Drug Controller General of India was quoted as saying by news agency ANI.
Bed-ridden for the last 15 years, a 65-year-old man from Bhadarwah in Jammu and Kashmir's Doda district was among three residents of the Union Territory who recently received the 'best construction award' under the Pradhan Mantri Awas Yojana (PMAY).
Moments after the Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus, the World Health Organisation (WHO) welcomed the decision. A statement by Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia Region read, "WHO welcomes the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region."
Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' is ready to roll out in the coming weeks. Poonawalla'' remarks came soon after after India's drugs regulator, Drug Controller General of India (DCGI) approved Covishield for restricted emergency use.
The Drug Controller General of India (DCGI) on Sunday approved the emergency use of both Oxford-AstraZeneca Covishield vaccine and Bharat Biotech’s Covaxin vaccine for immunisation against Covid-19 in India. Prime Minister Narendra Modi took to Twitter to appreciate India's vaccine against Coronavirus and said 'it would make every Indian proud.'
Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus. The development, eleven months after the first case of deadly coronavirus was detected in India, has paved the way for their roll-out and administration to millions. The vaccine will be first offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crores elderly, mostly above the age of 50 years with co-morbidities.Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...
